This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients

This study has been completed.
Information provided by:
University of Utah Identifier:
First received: December 16, 2008
Last updated: December 17, 2008
Last verified: December 2008
VTE prophylaxis is not as routinely employed in medically ill patients as compared to surgical patients. This retrospective chart review project will evaluate the effectiveness of VTE prophylaxis in medically ill patients at the University of Utah Hospitals and Clinics compared to current literature. The study will ultimately serve as a quality improvement project to help improve patient care.

Condition Intervention
Venous Thromboembolism Behavioral: Education

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients

Further study details as provided by University of Utah:

Enrollment: 121
Study Start Date: March 2005
Study Completion Date: March 2007
Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Patients cared for before our intervention.
Patients cared for after our intervention.
Behavioral: Education
(1) a risk-assessment tool completed at the time of a hospital admission, (2) structured educational sessions on VTE prevention, and (3) audit-feedback where institutional data was reviewed during the educational sessions. These sessions were given once to the clinical pharmacists and on three separate occasions to the medicine house officers.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Data was collected on consecutive patients ≥18 years with a hospital length of stay of >48 hours admitted to the cardiology, pulmonary, or general medical services. Admission dates were a sample of two different two-week blocks (January 1-14, 2006 and April 1-14, 2006). These blocks were chosen to be consistent with dates of analysis in the pre-intervention cohort. Patients receiving therapeutic anticoagulation were excluded.

Inclusion Criteria:

  • Hospitalized at the University of Utah on one our medical services.

Exclusion Criteria:

  • Patients received therapeutic anticoagulation.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00810784

United States, Utah
University of Utah Health Sciences Center
Salt Lake City, Utah, United States, 84132
Sponsors and Collaborators
University of Utah
Principal Investigator: Matthew Rondina, M.D. University of Utah
  More Information

Responsible Party: Robert Pendleton, M.D., Associate Professor, University of Utah, University of Utah Identifier: NCT00810784     History of Changes
Other Study ID Numbers: UUHSC-IRB-00018164
Study First Received: December 16, 2008
Last Updated: December 17, 2008

Keywords provided by University of Utah:
Venous Thromboembolism
Quality Improvement
Compliance with VTE prophylaxis

Additional relevant MeSH terms:
Venous Thromboembolism
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases processed this record on September 21, 2017